Skip to main content
. 2022 Nov 14;12(11):e060983. doi: 10.1136/bmjopen-2022-060983

Table 5.

Cost breakdown base-case results

Cost breakdown (US$) FLOT ECF/ECX Incremental
Cost of administration 380.28 336.72 43.56
Cost of management 493.33 1758.22 −1264.89
Second lines of treatment and supportive treatment 29 341.43 28 261.02 1080.41
Cost of adverse events 748.36 453.18 295.18
Cost of surgery 13 019.22 12 725.29 293.93
Drug costs 2250.81 1777.47 473.34

ECF/ECX, epirubicin, cisplatin plus fluorouracil or capecitabine; FLOT, fluorouracil, leucovorin, oxaliplatin plus docetaxel.